The justification for CRPC hormone therapy appears to be: “We’ve always done it that way!” The SoC in early-stage CRPC will change, IMO, but the change is apt to be slow. Urologists aren’t likely to cede this business without a fight.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.